Dermatology News
- What Are the Health Risks From Wildfire Smoke?
- Alert EU Approves Bimekizumab for PsA and AxSpA
- Is ChatGPT a Friend or Foe of Medical Publishing?
- Risk for Incident VTE Increased in Adults With AD
- Picosecond Lasers Effective for Treating Cosmetic Tattoos
- Dupilumab Outcomes Stable in Open-Label AD Study
- Abrocitinib Improvements Sustained in AD Extension Study
- FDA Approves Hyaluronic Acid Filler for Under-Eye Hollows
- Stelara Patent Deal Puts J&J Back on Path to Revenue Forecast
- When Could You Be Sued for AI Malpractice? You're Likely Using It Now
- EULAR 2023 EULAR SSc Recommendations Now Include Immunosuppressants
- EULAR 2023 Promising Telitacicept Results Reported for Lupus, Sjögren's
- Choosing SPF Is Only the Start When Recommending Sunscreens
- 7 Tactics to Reduce EHR Tasks and Save Time
- Why Not Both? Dual Biologics for RA and PsA
- Scientists Discover Genomic Variants for Rare Skin Disease
- EULAR 2023 ILD Risk Elevated in RA, PsA After Starting DMARDs
- Alert First IL-17 Inhibitor Approved in Europe for HS Patients
- Enthesitis Linked to Dupilumab Use for Atopic Dermatitis
- JAK-Inhibitor Safety in Adolescents With AD Reported